Skip to main content
Archit Organosys Limited logo

Archit Organosys Limited — Investor Relations & Filings

Ticker · 524640 ISIN · INE078I01011 LEI · 3358009G6SGQVG1SNZ21 BSE.NS Manufacturing
Open in API
Filings indexed 8 across all filing types
Latest filing 2026-05-18 Regulatory Filings
Country IN India
Listing BSE.NS 524640

About Archit Organosys Limited

https://architorg.com

Archit Organosys Limited specializes in the manufacturing and distribution of organic chemicals and chemical intermediates. The company's primary product portfolio includes Monochloroacetic Acid (MCA) and Sodium Monochloroacetate (SMCA), which serve as essential raw materials across diverse sectors such as pharmaceuticals, agrochemicals, surfactants, and food additives. Additionally, the firm produces various esters and specialty chemical derivatives. Archit Organosys emphasizes high-purity chemical synthesis and maintains advanced manufacturing facilities to meet international quality standards. Its operations focus on providing critical chemical building blocks for the global supply chain, supporting applications in oil drilling, dyes, and cosmetic industries. The company is committed to process innovation and expanding its technical capabilities in the organic chemistry domain.

Recent filings

Filing Released Lang Actions
Newspaper Publication regarding Notice of opening of Special Window for re-lodgement of transfer of shares.
Regulatory Filings Classification · 85% confidence The document is a notice sent to the BSE Listing Department under SEBI (LODR) Regulation 30, stating that a newspaper advertisement regarding a special window for re-lodgment of physical share transfer requests has been published and is enclosed. It does not contain financial statements or substantive report content but is a regulatory announcement to the exchange under listing regulations. Therefore it falls under the general Regulatory Filings category.
2026-05-18 English
Newspaper Publication regarding Audited Financial results for the Quarter and year ended on March 31, 2026.
Regulatory Filings Classification · 88% confidence The document is a formal letter to BSE under SEBI Listing Regulations (Regulation 30 and 47) notifying the exchange that newspaper advertisements have been published containing a QR code and link to the company’s audited financial statements for the quarter and financial year ended March 31, 2026. It does not include the financial statements themselves but is a compliance disclosure under listing rules. This falls under general regulatory announcements that do not fit other categories, hence Regulatory Filings (RNS).
2026-05-18 English
Approval of financial results for the quarter and financial year ended on March 31, 2026.
Interim / Quarterly Report Classification · 48% confidence The document is a board meeting outcome notice filed under SEBI LODR Reg.33 announcing and attaching the standalone audited financial results (including P&L, balance sheet, cash flows) for the quarter and year ended March 31, 2026. It contains full financial statements, not merely a brief earnings summary, but it is not a full annual report (10-K) with narrative, MD&A, corporate overview, etc. It is a regulatory quarterly/annual‐results filing with substantive financial data, consistent with our Interim/Quarterly Report definition. FY 2026
2026-05-16 English
The Board approved dividend subject to approval of Shareholders at ensuing AGM.
Interim / Quarterly Report Classification · 85% confidence The document is a formal stock‐exchange disclosure under SEBI Listing Regulations (Reg. 30 & 33) titled “Outcome of Board Meeting,” and it attaches the standalone audited financial results (including P&L, assets & liabilities, cash flow) and the independent auditor’s report for the quarter and financial year ended March 31, 2026. It contains substantive financial statements rather than mere highlights or a simple filing notification. While it covers the year-end audit, it is structured as a quarterly (Q4) audited result announcement under Indian practice (where Q4 results are audited) and includes detailed financial data. Therefore it fits the “Interim / Quarterly Report” category (Code: IR). FY 2026
2026-05-16 English
Approval of Audited financial results for the quarter and financial year ended on 31st March, 2026.
Earnings Release Classification · 85% confidence The document is a mandatory SEBI (Listing Obligations and Disclosure Requirements) Regulation 33 filing in which the Board approved and disclosed the audited financial results for the quarter and year ended March 31, 2026, along with the auditor’s report. It is not a full Annual Report (10-K), nor merely a report publication notice (RPA). It is the company’s initial announcement of periodical financial results – containing detailed numbers and auditor’s opinion – which aligns with an Earnings Release under our taxonomy. FY 2026
2026-05-16 English
Annual Secretarial Compliance Report for the year ended 31st March, 2026.
Regulatory Filings Classification · 87% confidence The document is titled “Annual Secretarial Compliance Report” prepared by the Company Secretary under SEBI LODR Regulation 24A. It is an attestation/certification of regulatory compliance rather than an actual financial report, AGM materials, earnings release, or other specific filings. Under the Certification Rule, such officer certifications and compliance reports are classified as Regulatory Filings (RNS).
2026-05-15 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.